J&J Win In Children's Motrin Suit Offers New Trial Tactic
Law360, New York (October 6, 2015, 12:56 PM EDT) -- Johnson & Johnson recently convinced a Pennsylvania federal jury that over-the-counter Children's Motrin didn't cause a child to develop the life-threatening skin condition Stevens-Johnson Syndrome, a win that attorneys say will help the pharmaceutical giant try more cases involving patients who took a little longer to develop the condition.
In a decision late September, the jury found that the plaintiffs had not shown that over-the-counter Children’s Motrin caused 3-year-old Riley Brown to develop the horrific skin condition that left her blind. Since the jury ruled in favor of J&J on causation, it did not consider the question on the adequacy of its...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!